We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease.
- Authors
Valenzuela-Vallejo, Laura; Sanoudou, Despina; Mantzoros, Christos S.
- Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non-invasive diagnosis and effective treatment remain an unmet clinical need. NAFLD is a heterogeneous disease that is most commonly present in the context of metabolic syndrome and obesity, but not uncommonly, may also be present without metabolic abnormalities and in subjects with normal body mass index. Therefore, a more specific pathophysiology-based subcategorization of fatty liver disease (FLD) is needed to better understand, diagnose, and treat patients with FLD. A precision medicine approach for FLD is expected to improve patient care, decrease long-term disease outcomes, and develop better-targeted, more effective treatments. We present herein a precision medicine approach for FLD based on our recently proposed subcategorization, which includes the metabolic-associated FLD (MAFLD) (i.e., obesity-associated FLD (OAFLD), sarcopenia-associated FLD (SAFLD, and lipodystrophy-associated FLD (LAFLD)), genetics-associated FLD (GAFLD), FLD of multiple/unknown causes (XAFLD), and combined causes of FLD (CAFLD) as well as advanced stage fibrotic FLD (FAFLD) and end-stage FLD (ESFLD) subcategories. These and other related advances, as a whole, are expected to enable not only improved patient care, quality of life, and long-term disease outcomes, but also a considerable reduction in healthcare system costs associated with FLD, along with more options for better-targeted, more effective treatments in the near future.
- Subjects
FATTY liver; NON-alcoholic fatty liver disease; INDIVIDUALIZED medicine; SARCOPENIA; LIVER diseases; BODY mass index
- Publication
Journal of Personalized Medicine, 2023, Vol 13, Issue 5, p830
- ISSN
2075-4426
- Publication type
Article
- DOI
10.3390/jpm13050830